title: Acquisition of iron by Legionella pneumophila: role of iron reductase.
abstract: Legionella pneumophila has been shown to survive and multiply in a variety of intracellular environments, including protozoa and human mononuclear phagocytes. However, the mechanism by which this organism acquires iron in the intracellular environment has not been studied. Since L. pneumophila does not produce siderophores, alternative methods of iron acquisition were investigated. Virulent strains of L. pneumophila were able to grow in media containing as little as 3 microM iron, whereas avirulent cells required a minimum of 13 microM iron for growth. Neither virulent nor avirulent cells were able to utilize 55Fe bound to transferrin. When incubated in the presence of 55Fe in the form of ferric chloride, both virulent and avirulent cells accumulated equal amounts of iron. The uptake of iron was energy dependent as indicated by inhibition of 55Fe uptake at 4 degrees C and preincubation of the cells with KCN. Treatment of virulent cells with pronase or trypsin had no effect on iron uptake. In contrast, pronase or trypsin treatment of avirulent cells resulted in increased uptake of iron. Iron reductase activity in both virulent and avirulent cells was demonstrated, with the highest specific activity associated with the periplasmic fraction. Maximum reductase activity of virulent cells occurred with NADH as the reductant. In contrast, avirulent cells showed a twofold increase in enzyme activity when NADPH was used as the reductant. These results suggest that an iron reductase is important in iron acquisition by L. pneumophila.
authors.affiliation: Department of Microbiology, University of Iowa, Iowa City 52242.
authors.forename: W
authors.initials: W
authors.lastname: Johnson
authors.forename: L
authors.initials: L
authors.lastname: Varner
authors.forename: M
authors.initials: M
authors.lastname: Poch
mesh_terms: D001692:Biological Transport; D004533:Egtazic Acid / Q000378:metabolism; D038181:FMN Reductase; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007501:Iron / Q000378:metabolism*; D007875:Legionella / Q000378:metabolism* / Q000472:pathogenicity; D010088:Oxidoreductases / Q000378:metabolism*; D011402:Pronase / Q000494:pharmacology; D014168:Transferrin / Q000378:metabolism; D014357:Trypsin / Q000494:pharmacology
chemical_list: D014168:Transferrin; D004533:Egtazic Acid; D007501:Iron; D010088:Oxidoreductases; D038181:FMN Reductase; C023903:ferric citrate iron reductase; D014357:Trypsin; D011402:Pronase